Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Long E et al. - The study demonstrates that late tumour stages of KS in tissues from HIV-positive patients are associated with high levels of LANA-1, HIF-1 alpha and of the anti-apoptotic proteins, Bcl-2 and Mcl-1. Finally, the expression of these proteins can be potentially used as a tissue biomarker in defining patients with a higher risk of disease progression.

Related Articles

Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid
Clinical Infectious Diseases, 11/16/09    Relevance Score: 67%

Immunohistochemistry in Kaposis sarcoma
Clinical and Experimental Dermatology, 10/28/09    Relevance Score: 67%

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study : The Lancet Oncology
The Lancet Oncology - Online First, 10/12/09    Relevance Score: 66%

C-Kit (CD117) expression in classic Kaposis sarcoma
Clinical and Experimental Dermatology, 11/02/09    Relevance Score: 65%

Detection of Human Herpesvirus 8 in the Skin of Patients with Pityriasis Rosea
Acta Dermato-Venereologica, 10/29/09    Relevance Score: 64%

Today in Basic Science/Genetics...keeping you current

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 11/30/09

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09

Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: A meta-analysis involving 46,281 subjects
Breast Cancer Research and Treatment, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address